Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionReactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsBacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism.Cytokine influence on simian immunodeficiency virus replication within primary macrophages. TNF-alpha, but not GMCSF, enhances viral replication on a per-cell basisRegulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.Host hindrance to HIV-1 replication in monocytes and macrophages.A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.Lipopolyamines: novel antiendotoxin compounds that reduce mortality in experimental sepsis caused by gram-negative bacteria.HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.C/EBP beta regulation of the tumor necrosis factor alpha gene.Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expressionLeishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms.Candida albicans delays HIV-1 replication in macrophages.Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB.Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanismsActivation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.Activation of caprine arthritis-encephalitis virus long terminal repeat by gamma interferon.Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages.Proline-proline-glutamic acid (PPE) protein Rv1168c of Mycobacterium tuberculosis augments transcription from HIV-1 long terminal repeat promoter.Host factors influencing susceptibility to HIV infection and AIDS progression.Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection.Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages.Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage.Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites.Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosaA family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells.Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events.Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivoBacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes.Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication.Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophagesCell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cellsAnalysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2.Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.The NF-kappa B binding site is necessary for efficient replication of simian immunodeficiency virus of macaques in primary macrophages but not in T cells in vitro.Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.
P2860
Q24550678-42E4EB4C-D00F-4637-BC06-F7A18B4697F3Q24564855-3EF2E144-B65A-420C-8C96-C2BAEA299221Q24651506-F6AFDAB0-1B48-484D-8AE1-6858A7FE978CQ27469350-3CEF5F6A-B832-4499-AFE7-57121B9158EDQ33417664-A39D47D3-565F-4A1B-85B5-395E9761BF5FQ33587139-78CA9CA4-5222-4558-A8C9-9B424DE63C33Q33846376-0F45275D-ABB4-4165-90FC-356C5E1EDCFBQ33889449-DAC14856-2E86-41E6-943E-2CD157C8A567Q33976703-F298AB19-E887-4324-B1D5-C092BB78CA51Q34150444-D355D05C-FCE6-46F6-B60C-CC0D21D7C580Q34188989-2A2394E6-1030-4890-932D-7B1C4E0BB122Q34193240-3CE265B9-2CC5-48BE-99BF-AFBE91C7F121Q34229670-A28AB1D5-4C08-435F-A5AF-A7A483F7B006Q34284119-D37EC25E-1D03-47B7-A2AE-27211E528F00Q34979635-FA245F04-3415-4053-805E-04C2C3B5CA51Q34982684-318FDC29-FE7C-4642-ADA1-A32C05B47326Q35274791-F0B8F977-9E75-4D36-9180-D2A939D8D456Q35519550-883F406B-D383-4B28-8BB5-C3058346E75FQ35556260-5578930A-EAC7-49EA-B3F6-D4431B5DCBCCQ35853939-766DBE79-DE0F-4237-9647-3F420BB79165Q35878462-4D858A9B-A873-4180-9DF2-F06D13AA5F88Q35956508-32E749E5-1338-48DC-8891-F3CF392199B6Q35995936-FE12B19D-CE52-492B-A0FD-BC2CEBDA15D4Q36099361-5A17B3F1-34C1-4460-B880-ACFC03F64D6CQ36136378-9E4655B9-6A47-4AE8-A90A-79DEC7509DAFQ36229933-3EDB135E-1A8E-40D5-BB93-561C41C7CD6BQ36230640-CACAA786-A66C-4DFB-B791-8476CCA3FF71Q36231310-B24FEC20-A5B4-4E38-9BB7-E817E02DCA36Q36363786-3ED93CC6-1994-4AB5-A568-9FD97F2E7DCCQ36363889-7F5E48EB-4586-462D-9DFB-617DF866707BQ36365140-C242CDAE-C3D4-4887-AE1C-10A03B7D7CA1Q36366381-0672C834-5941-4B36-A609-92468DEA5EF2Q36376839-227876C4-AEE4-4249-8964-608DC6B24086Q36401561-70FCF98F-D808-450E-8267-11D2A3B27E76Q36509253-81F5C70F-4CDA-4AD4-B652-A53041482771Q36619988-50887126-DB3A-45A9-A62B-E39990F94098Q36630643-F40A8488-6B44-4C8E-8039-0BF1D4EB27AAQ36634412-1F82F187-3940-478D-BF0E-54F0A311DDC0Q36646158-724036DE-232D-4D19-9867-EB3D77B0A1CDQ36648682-5D223520-005C-4AC0-A63D-772CD7539F05
P2860
Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Lipopolysaccharide is a potent ...... iency virus type 1 expression.
@ast
Lipopolysaccharide is a potent ...... iency virus type 1 expression.
@en
type
label
Lipopolysaccharide is a potent ...... iency virus type 1 expression.
@ast
Lipopolysaccharide is a potent ...... iency virus type 1 expression.
@en
prefLabel
Lipopolysaccharide is a potent ...... iency virus type 1 expression.
@ast
Lipopolysaccharide is a potent ...... iency virus type 1 expression.
@en
P2093
P2860
P356
P1476
Lipopolysaccharide is a potent ...... iency virus type 1 expression.
@en
P2093
D Baltimore
M B Feinberg
R J Pomerantz
P2860
P304
P356
10.1084/JEM.172.1.253
P407
P577
1990-07-01T00:00:00Z